Part 1: Exploring the background of person-centred care across the spectrum of related cardiometabolic diseases
Part 2: Focusing in on an expanding spectrum of cardiometabolic diseases and patient phenotypes
Part 3: Semaglutide and the path to holistic cardiometabolic disease care
Part 4: The future chapters - advancing the management of cardiometabolic diseases
Part 5: Innovating our heritage - once-weekly basal insulin therapy